Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tegimenta is a leading Argentine pharmaceutical company and a core component of the Roemmers Group, one of the most influential healthcare organizations in Latin America. The company specializes in the development and large-scale manufacturing of high-complexity pharmaceutical products, particularly in the fields of oncology, cardiology, and gastroenterology. Operating from its advanced facility in Munro, Buenos Aires, Tegimenta adheres to rigorous international quality standards, including Good Manufacturing Practices (GMP). Its portfolio includes a wide range of branded generics and specialty medications that serve both the domestic Argentine market and various international territories. As a key manufacturing hub, the company supports the broader group's mission to provide accessible and effective healthcare solutions across the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tegimenta.